226 related articles for article (PubMed ID: 20732759)
1. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
[TBL] [Abstract][Full Text] [Related]
2. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
3. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
[TBL] [Abstract][Full Text] [Related]
4. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
Seco J; Panahandeh HR; Westover K; Adams J; Willers H
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):354-61. PubMed ID: 21985941
[TBL] [Abstract][Full Text] [Related]
5. Can protons improve SBRT for lung lesions? Dosimetric considerations.
Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
[TBL] [Abstract][Full Text] [Related]
6. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
Xia T; Li H; Sun Q; Wang Y; Fan N; Yu Y; Li P; Chang JY
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):117-25. PubMed ID: 16765528
[TBL] [Abstract][Full Text] [Related]
7. Photons or protons: precision radiotherapy of lung cancer.
Auberger T; Seydl K; Futschek T; Sztankay A; Sweeney RA; Lukas P
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():3-6. PubMed ID: 18166995
[No Abstract] [Full Text] [Related]
8. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
[TBL] [Abstract][Full Text] [Related]
9. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
10. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
[TBL] [Abstract][Full Text] [Related]
11. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
Matsuo Y; Shibuya K; Nagata Y; Takayama K; Norihisa Y; Mizowaki T; Narabayashi M; Sakanaka K; Hiraoka M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1104-11. PubMed ID: 20472343
[TBL] [Abstract][Full Text] [Related]
13. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
14. Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer.
Arvidson NB; Mehta MP; Tomé WA
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1597-603. PubMed ID: 19028283
[TBL] [Abstract][Full Text] [Related]
15. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric evaluation of a conformal seven-field coplanar technique for planning lung stereotactic body radiotherapy.
Richmond N; Green J; Peedell C; Shakespeare D; Walker C
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e24-30. PubMed ID: 21763114
[TBL] [Abstract][Full Text] [Related]
17. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.
Dvorak P; Georg D; Bogner J; Kroupa B; Dieckmann K; Pötter R
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1572-81. PubMed ID: 15817364
[TBL] [Abstract][Full Text] [Related]
18. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity.
Ong CL; Palma D; Verbakel WF; Slotman BJ; Senan S
Radiother Oncol; 2010 Dec; 97(3):431-6. PubMed ID: 20971523
[TBL] [Abstract][Full Text] [Related]
19. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
